References
- WhitneyCGFarleyMMHadlerJIncreasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United StatesN Engl J Med20003431917192411136262
- ForierKRaemdonckKDe SmedtSCDemeesterJCoenyeTBraeckmansKLipid and polymer nanoparticles for drug delivery to bacterial biofilmsJ Control Release201419060762324794896
- MeersPNevilleMMalininVBiofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infectionsJ Antimicrob Chemother20086185986818305202
- LiechtyWBKryscioDRSlaughterBVPeppasNAPolymers for drug delivery systemsAnnu Rev Chem Biomol Eng2010114917322432577
- GuzmanMDilleJGodetSSynthesis and antibacterial activity of silver nanoparticles against Gram-positive and Gram-negative bacteriaNanomedicine20128374521703988
- BaharAARenDAntimicrobial peptidesPharmaceuticals201361543157524287494
- HazraMSinghSKRaySSurface modification of liposomal vaccines by peptide conjugationJ PharmSciTech201114147
- LiuXHuangGFormation strategies, mechanism of intracellular delivery and potential clinical applications of pH-sensitive liposomesAsian J Pharm Sci20138319328
- Gomes-da-SilvaLCFonsecaNAMouraVde LimaMCSimõesSMoreiraJNLipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challengesAcc Chem Res2012451163117122568781
- VidalMHoekstraDIn vitro fusion of reticulocyte endocytic vesicles with liposomesJ Biol Chem199527017823178297629083
- NicolosiDScaliaMNicolosiVMPignatelloREncapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteriaInt J Antimicrob Agents20103555355820219328
- PignatelloRNicolosiDNicolosiVMFusogenic liposomes as new carriers to enlarge the spectrum of action of antibiotic drugs against Gram-negative bacteriaMéndez-VilasAScience Against Microbial Pathogens: Communicating Current Research and Technological AdvancesBadajoz, SpainFormatex Research Center20115260
- StalmansSBrackeNWynendaeleECell-penetrating peptides selectively cross the blood-brain barrier in vivoPLoS One201510e013965226465925
- TunkelARHartmanBJKaplanSLPractice guidelines for the management of bacterial meningitisClin Infect Dis2004391267128415494903
- ZongTMeiLGaoHSynergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animalsMol Pharm2014112346235724893333
- El-AshrySMBelalFEl-KerdawyMMEl WasseefDRSpectrophotometric determination of some phenolic antibiotics in dosage formsMicrochim Acta2000135191196
- SmithJWde GreyGEPatelVJSpectrophotometric determination of ampicillinAnalyst1967922472526046816
- WeaverWJReschkeRFSpectrophotometric determination of sodium 2,6 dimethoxyphenyl penicillin monohydrate (methicillin)J Pharm Sci19635236236413999319
- ChakrabortySPSahuSKPramanikPRoySIn vitro antimicrobial activity of nanoconjugated vancomycin against drug resistant Staphylococcus aureusInt J Pharm2013436659676
- EllbogenMHOlsenKMGentry-NielsenMJPreheimLCEfficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumoniaJ Antimicrob Chemother200351839112493791
- DiepBAGillSRChangRFComplete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureusLancet200636773173916517273
- BabaTTakeuchiFKurodaMGenome and virulence determinants of high virulence community-acquired MRSALancet20023591819182712044378
- KlevensRMMorrisonMANadleJInvasive methicillin-resistant Staphylococcus aureus infections in the United StatesJAMA20072981763177117940231
- CordeiroCWisemanDJLutwychePAntibacterial efficacy of gentamicin encapsulated in pH-sensitive liposomes against an in vivo Salmonella enterica serovar Typhimurium intracellular infection modelAntimicrob Agents Chemother20004453353910681314
- TakeshimaKChikushiALeeKKYoneharaSMatsuzakiKTranslocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranesJ Biol Chem20032781310131512417587